IQVIA Holdings Inc. IQV
Super Investor & Insider
4
Fondi che lo detengono
#174
Rank consenso
5.7%
% dei portafogli
$2.42B
Valore detenuto
| Fondo | % portaf. | Attività | Azioni | Valore |
|---|---|---|---|---|
| Bill Nygren · Harris Associates | 2.77% | Add 7.63% | 12,183,275 | $2.08B |
| William Von Mueffling · Cantillon Capital Management | 1.94% | Reduce 11.86% | 1,710,896 | $291.8M |
| Vulcan Value Partners · Vulcan Value Partners | 1.12% | Buy | 248,101 | $42.3M |
| Thomas Gayner · Markel Group | 0.07% | — | 46,900 | $8.0M |
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company supports pharmaceutical, biotechnology, medical device, and healthcare organizations in developing, testing, and commercializing therapies using extensive real-…
SectorHealthcare
ExchangeNYSE
IndustryDiagnostics & Research
CountryUnited States
Employees93,000
TickerIQV
Statistics
Market Cap$28.52B
Revenue (TTM)$16.31B
Net Income$1.36B
Net Margin8.3%
EPS$7.84
P/E22.80
P/S1.84
P/B4.92
EV/EBITDA15.10
ROE22.5%
Dividend Yield—
Price$170.90
Data: Twelve Data · Revenue = mcap / P/S